All Updates

HARRISBURG, PA – OCTOBER 12, 2023 – Today, Rep. Kyle Mullins introduced House Bill 1754 to increase Pennsylvanians’ access to biomarker testing, following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week. A game-changing part of cancer care, biomarker testing opens the door

WASHINGTON, D.C.— October 12, 2023 — Next Wednesday, the Senate Health Education Labor and Pensions Committee has scheduled a hearing on the confirmation of Dr. Monica Bertagnolli as the next director of the National Institutes of Health (NIH). The American Cancer Society Cancer Action Network sent a letter to

WASHINGTON, D.C. – October 12, 2023 –Today, the American Cancer Society and the American Cancer Society Cancer Action Network (ACS CAN) joined with other leading national patient groups in filing an amicus curiae (or friend-of-the-court) brief urging the Supreme Court to take up the case of

Today, the American Cancer Society Cancer Action Network (ACS CAN) was overjoyed to see the legislature pass oral chemotherapy fairness legislation. ACS CAN looks forward to seeing the Governor sign this critical legislation into law soon and celebrating our volunteers’ hard work to get this legislation over the finish line.

Governor Gavin Newsom announced he had vetoed Assembly Bill 374, which aimed to allow local jurisdictions to permit cannabis retailers to prepare and sell food and beverages that do not contain cannabis.

Governor Gavin Newsom announced he had vetoed Assembly Bill 374, which aimed to allow local jurisdictions to permit cannabis retailers to prepare and sell food and beverages that do not contain cannabis.

California Governor Gavin Newsom announced he has signed Senate Bill 496, ensuring that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing when supported by medical and scientific evidence.

California Governor Gavin Newsom announced he has signed Senate Bill 496, ensuring that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing when supported by medical and scientific evidence.